Pharmaceutical Industry

Moderna’s Strategic Shift Toward Oncology Therapeutics Drives Significant Market Growth

Biotechnology firm Moderna experienced a dramatic market resurgence over the past year, with its stock surging by 177 percent following a strategic pivot toward oncology development. Driven by declining revenues…

srkanalytics.srk@gmail.com August 21, 2026

Health

Trump Nominates Heidi Overton for F.D.A. Commissioner

President Donald Trump has officially nominated Dr. Heidi Overton, a prominent domestic policy aide and vocal opponent of abortion rights, to serve as the next commissioner of the Food and…

srkanalytics.srk@gmail.com August 20, 2026

Business

Sun Pharma Secures Favorable Verdict in U.S. Antitrust Litigation

Sun Pharmaceutical Industries has secured a decisive legal victory in the United States following a favorable verdict in a long-standing antitrust lawsuit. According to official reports, a federal court ruled…

srkanalytics.srk@gmail.com August 18, 2026

Business

Alembic Pharma Secures U.S. FDA Approval for Generic Chronic Constipation Medication

Alembic Pharmaceuticals announced on Tuesday that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its generic Linaclotide capsules. The medication, prescribed for…

srkanalytics.srk@gmail.com July 29, 2026

Business

Laurus Labs Reports Q1 Profit Surge Driven by 69% Jump in Small Molecule CDMO Division

Hyderabad-based pharmaceutical major Laurus Labs reported a more than twofold increase in consolidated net profit for the first quarter of the fiscal year, propelled by extraordinary growth in its Contract…

srkanalytics.srk@gmail.com July 25, 2026

Business

Laurus Labs Net Profit More Than Doubles in Q1 on CDMO Expansion

Indian generic drug maker Laurus Labs reported a dramatic surge in its first-quarter net profit this week, more than doubling its earnings compared to the same period last year. The…

srkanalytics.srk@gmail.com July 25, 2026

Business

Dr. Reddy’s Biologics Facility Faces Fresh FDA Scrutiny with Seven Observations

The U.S. Food and Drug Administration (FDA) recently issued a Form 483 with seven observations to Dr. Reddy's Laboratories' biologics manufacturing facility in Hyderabad, India, following a routine inspection, signaling…

srkanalytics.srk@gmail.com June 26, 2026